Navigation Links
SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
Date:11/22/2011

WASHINGTON, LONDON and HONG KONG, Nov. 22, 2011 /PRNewswire/ --SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced that Neil J. Campbell, President and CEO, will be presenting at the 23rd Annual Piper Jaffray Healthcare Conference on November 30, 2011 at 10:30 a.m. ET at the New York Palace – 455 Madison Avenue, New York.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology and additional details on the company's recent commercial partnership with Concile, GmbH.

Mr. Campbell stated, "Demand for SuperNova's AmpCrystal® platform is rapidly accelerating, both in the field, as evidenced by our recent commercial partnership with Concile, and among industry and investment professionals.  The Piper Jaffray Healthcare Conference provides an ideal forum for reaching this latter group and to showcase the diagnostic and revenue potential of our POC/POU technology."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / June Gregg
(212) 827-0020
jrando@tiberend.com / jgregg@tiberend.com

 

 

 

 


'/>"/>
SOURCE SuperNova Diagnostics(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
2. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
3. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
4. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
5. PRA Expert to Present at Pharmacovigilance Conference
6. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
7. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
8. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
9. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
10. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
11. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... ... September 12, 2018 , ... NDA Partners ... and former Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., ... of Regulatory Affairs and Quality Systems at WellDoc, Inc., she conducted quality control ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on Target ... of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput ... study these emerging targets in a quest to find new treatments for disease. ...
(Date:9/7/2018)... ... September 06, 2018 , ... Flagship Biosciences’ MuscleMap algorithm ... to be as effective as manual pathology. The study, “Validation of a Muscle-Specific ... was published in the Archives of Pathology & Laboratory Medicine on August 31, ...
(Date:9/1/2018)... (PRWEB) , ... August 31, 2018 , ... ... research results of the impact of a proprietary biofield energy treated nutraceutical supplement ... assessed biomarkers for immune function response and blood, as well as, organ-specific inflammation. ...
Breaking Biology Technology:
(Date:9/7/2018)... ... September 05, 2018 , ... Following up on ... late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed ... The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its ... directly related to the spine that result from it. The deal will make ...
(Date:8/31/2018)... ... August 30, 2018 , ... R3 Stem Cell, the ... for new clients. The freezers are very convenient for practices to maintain regenerative ... consist of amniotic and umbilical cord tissue. They are stored at -80 degrees ...
Breaking Biology News(10 mins):